Can blood stem cells predict diabetic eye disease?

NCT ID NCT02119689

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at blood stem cells (called EPCs) in people with and without diabetes to see if they work differently. Researchers want to know if these cells can predict diabetic retinopathy, an eye disease that can cause vision loss. The study involves 78 adults, including 39 with diabetes and 39 healthy controls, and measures cell function through blood tests and a simple finger monitor.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors predict who will develop diabetic retinopathy, allowing for earlier monitoring or treatment.

What could go wrong

This is an observational study, not a treatment trial. It may not lead to any direct medical benefit, and the results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus diabetic retinopathy retinal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Alabama

    Birmingham, Alabama, 35294, United States